FDA Investigator Rebecca K Olin
Rebecca K Olin has conducted inspections on 15 sites in 6 countries as of 21 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
21 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Belgium,
France,
Italy,
Germany,
Sweden
FDA Investigators that have inspected at least one site in common with Rebecca K Olin:
Aikaterini Alexaki,
Alan L Truong,
Alicia M Mozzachio,
Alla Kachko, PhD,
Amir Alavi,
Anastasia I Offordile,
Andrey Sarafanov, PhD,
Angela K Shen,
Anissa M Cheung,
Anita R Michael,
Ann L Demarco,
Ann Marie Montemurro,
Ann Marie Schofield,
Anthony F Lorenzo,
Ashley N Queen, PhD,
Audrey Thereset Uy,
Ava M Bowman,
Barry Cherney, PhD,
Benjamin J Smith,
Brentley S Collins,
Brian D Nicholson,
Brian S Keefer,
Bruce H Mccullough,
Burnell M Henry,
Carrie A Hughes,
Carrie Ann Plucinski,
Caryn M Everly,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
CDR Donald Ertel,
CDR Jeremy L Wally, PhD,
Chao Ming Tsai,
Charles M Spyr,
Chava Kimchi Sarfaty, PhD,
Cheng H Yen,
Christian D Lynch (CDL),
Christina A Miller,
Christina J Sauder, PhD,
Christina V Santos,
Christopher J Adams,
Christopher R Czajka,
Constantin Y Philopoulos,
Craig D Zagata,
Cynthia Jim, CSO,
Darla J Christopher,
Dave Hafner,
David A Paterson,
David G Whitman,
David J Hafner,
David Perkins,
Debra I Love,
Debra J Bennett,
Debra L Pagano,
Destry M Sillivan,
Deyaa Shaheen,
Dino A Fiegelstock,
Dmitriy V Volokhov, PhD,
Dr. Gang Wang, PhD,
Dr. Willie F Vann, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Eileen A Liu,
Eliezar Ramos,
Ellen Huang,
Emest F Bizjak,
Emily J Orban,
Enrico Joset Mangahis,
Esther C Broner, PhD,
Felice D'agnillo, PhD,
Gene D Arcy,
Grace Deneke,
Hala L Selby,
Haruhiko Murata,
Helen B Ricalde,
Humera T Khan,
Ifueko Osemwota,
J David Doleski,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
James E Keller, PhD,
James M Mason,
James R Evans,
Jason F Chancey,
Jeanne M Morris,
Jeffrey A Sommers,
Jeffrey D Meng,
Jennifer L Reed,
Jennifer L Schmidt,
Jennifer M Gogley,
Jie He,
Joan A Loreng,
Joan Adamo,
Joanne M Hajoway,
Joey V Quitania,
John F Cipollo,
John M Mcinnis,
Jonathan Mclnnis,
Joseph George,
Joyce A Rockwell,
Julianne C Mccullough,
Julie D Bringger,
Junho Pak,
Justin A Boyd,
Karyn M Campbell,
Katherine E Jacobitz,
Kathleen B Mihalik,
Kathryn Carbone, MD,
Kelly N Kerr,
Kenneth M Gordon,
Kevin P Foley,
Kirsten L Vadheim, PhD,
Kristen D Evans,
Larry K Austin,
Lata C Mathew, PhD,
Laurie P Norwood,
Laurimer Kuilan Torres,
LCDR Debra Emerson,
LCDR Margaret Edi Gennaro,
Lequita M Mayhew,
Leslie D Wagner,
Lestine C Webb,
Lewis K Antwi,
Linda Thai,
Lisa M Bellows,
Lisa M Feola,
Lorelei S Jarrell,
LT John M Mastalski,
Marian E Major, PhD,
Marian Majors, PhD,
Marion Michaelis,
Mariza M Jafary,
Meisha R Sampson,
Meisha Waters,
Michael C Kennedy, PhD,
Michael Curbarg,
Michael Gurbarg,
Michael J Vardon,
Michael Merchlinsky,
Michael Shanks, MS,
Michael T Cyrus,
Michele L Forster, PhD,
Michele L Glendenning,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Nancy Kirschbaum, PhD,
Natalya M Ananyeva,
Nawab A Siddiqui,
Nayan J Patel,
Nicholas F Lyons,
Nicholas Obiri, PhD,
Nicholas P Diorio,
Nicole J Clausen,
Nicole K Trudel,
Nikisha M Bolden,
Olga Simakova, PhD,
Omotunde O Osunsanmi,
Pankaj H Amin,
Patsy J Domingo,
Paul A Bonneau,
Paula A Trost,
Peng Zhou,
Phung Thien Nguyen,
Pote Amin,
Prabhu P Raju,
Qiao Y Bobo,
Ralph A Erickson,
Ramon E Martinez,
Randa Melhem, PhD,
Rebecca E Dombrowski,
Richard Heath Coats,
Richard W Thornton,
Robert B Shibuya, MD,
Robert D Tollefsen,
Robert Jennings,
Robert M Barbosa,
Robert Sausville,
Robin Levis, PhD,
Roger F Zabinski,
Roman T Drews, PhD,
Rona Leblanc, PhD,
Rose Ashley,
Rose Xu,
Russ R Rivy,
Russell K Riley,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sarah B Tanksley,
Sarah M Meng,
Sarah M Napier,
Scott E Norris,
Scott T Ballard,
Sheila Dreher Lesnick,
Shirley J Berryman,
Shuang Tang,
Sidney B Priesmeyer,
Simone E Pitts,
Solomon Yimam (SY),
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Steven A Rubin,
Susan F Laska, MS,
Susan M Jackson,
Susan P Bruederle,
Susan Yu,
Svetlana A Shestopal,
Taichun Qin, PhD,
Tammy L Chavis,
Thai D Truong,
Thuy T Nguyen, LCDR,
Tina S Roecklein,
Todd M Stankewicz,
Travis S Bradley,
Unnee Ranjan,
Virgilio F Pacio, CSO,
Virginia Carroll, PhD,
Vlada Matusovsky,
Wei Wang, PhD,
Xiao Wang,
Yi Wang, PhD,
Yiping Jia,
Yiwei Li,
Ze Peng,
Zhiping Ye, PhD
Rebecca K Olin's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2010 | FDA 483 | CAF-DAF scrl - Form 483, 2010-09-15 |
| September, 2007 | FDA 483 | GlaxoSmithKline Biologicals SA - Form 483, 2007-09-21 |
| July, 2013 | EIR | Stallergenes - EIR, 2013-07-02 |
| April, 2011 | FDA 483 | Ajinomoto Althea, Inc. - Form 483, 2011-04-01 |
| April, 2002 | FDA 483 Response | AbbVie Inc. - Form 483R, 2002-04-29 |
| April, 2002 | EIR | AbbVie Inc. - EIR, 2002-04-25 |
| July, 2013 | FDA 483 | CENEXI - Form 483, 2013-07-05 |
| April, 2002 | FDA 483 | AbbVie Inc. - Form 483, 2002-04-25 |
| July, 2013 | FDA 483 | Stallergenes - Form 483, 2013-07-02 |
| May, 2011 | FDA 483 | SmithKline Beecham Pharma GmbH & Co. KG (dba GlaxoSmithKline Biologicals) - Form 483, 2011-05-05 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more